Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sanofi ( (SNY) ) has provided an announcement.
Sanofi has announced the appointment of Jean-Paul Kress as an independent director to its Board, effective January 1, 2025. Kress, with over 30 years of experience in the pharmaceutical industry, replaces Gilles Schnepp and will contribute to Sanofi’s strategic evolution in the biopharmaceutical field.
More about Sanofi
Sanofi is a global healthcare company focused on transforming medicine to improve lives. It offers life-changing treatment options and vaccines, with a strong emphasis on sustainability and social responsibility. Sanofi is publicly traded on EURONEXT and NASDAQ.
YTD Price Performance: -1.14%
Average Trading Volume: 2,219,385
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $119.6B
Learn more about SNY stock on TipRanks’ Stock Analysis page.
